HPHTF(HPHTF)
HPHTF
No analyst ratings available
No analyst price targets available for HPHTF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $233.28B | $249.63B | $267.57B | $277.74B | $286.26B |
| Low | $226.57B | $236.96B | $256.82B | $266.58B | $274.76B |
| High | $240.20B | $263.17B | $278.92B | $289.52B | $298.40B |
| EBITDA Avg | $49.05B | $54.83B | $62.46B | $65.52B | $63.03B |
| Low | $47.78B | $53.34B | $60.66B | $63.65B | $61.37B |
| High | $50.40B | $56.41B | $64.36B | $67.50B | $64.78B |
| EBIT Avg | $24.85B | $28.99B | $34.84B | $36.21B | $32.14B |
| Low | $23.58B | $27.49B | $33.04B | $34.34B | $30.48B |
| High | $26.20B | $30.57B | $36.74B | $38.19B | $33.89B |
| Net Income Avg | $17.39B | $20.33B | $24.48B | $25.46B | $22.57B |
| Low | $16.48B | $19.27B | $23.20B | $24.13B | $21.39B |
| High | $18.35B | $21.45B | $25.83B | $26.86B | $23.82B |
| EPS Avg | $57.94 | $67.73 | $81.56 | $84.82 | $75.19 |
| Low | $54.92 | $64.19 | $77.31 | $80.39 | $71.27 |
| High | $61.14 | $71.46 | $86.06 | $89.50 | $79.34 |
| Analysts (Rev / EPS) | 7 / 1 | 8 / 1 | 3 / 1 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $64.74B | $60.07B | $61.08B | $61.48B | $62.29B |
| Low | $63.94B | $58.62B | $59.97B | $60.37B | $61.16B |
| High | $65.32B | $61.53B | $62.09B | $62.49B | $63.31B |
| EBITDA Avg | $24.01B | — | — | — | — |
| Low | $23.60B | — | — | — | — |
| High | $24.38B | — | — | — | — |
| EBIT Avg | $18.01B | — | — | — | — |
| Low | $17.59B | — | — | — | — |
| High | $18.38B | — | — | — | — |
| Net Income Avg | $12.44B | — | — | — | — |
| Low | $12.15B | — | — | — | — |
| High | $12.71B | — | — | — | — |
| EPS Avg | $43.04 | — | — | — | — |
| Low | $42.02 | — | — | — | — |
| High | $43.96 | — | — | — | — |
| Analysts (Rev / EPS) | 4 / 1 | 2 / — | 1 / — | 1 / — | 1 / — |